Scott LeMaire, MD
Jimmy and Roberta Howell Professor of Cardiovascular Surgery
Vice-Chair for Research, Michael E. DeBakey Department of Surgery
Professor of Molecular Physiology and Biophysics
Director of Research, Division of Cardiothoracic Surgery
Baylor College of Medicine
Office of Surgical Research
Baylor College of Medicine Medical Center
Physician Associate, Cardiovascular Surgery, Texas Heart Institute
Overview:
Dr. LeMaire will describe the clinical and basic science evidence supporting concerns regarding the use of fluoroquinolones in patients at risk for aortic disease, and to provide an update on the current warnings about the aortic risks associated with using these medications.
Learning Objectives:
At the conclusion of the activity a participant should be able to:
- Describe the newest scientific evidence about the risks of using fluoroquinolones in patients with aortic disease.
- Explain the latest warnings that have been released by the FDA in the United States and the EMA in the EU.
- Discuss how to apply these warnings to your clinical practice.
Disclosures:
Scott A. LeMaire, MD is a consultant for Terumo Aortic & Cerus; he is a principal investigator for clinical studies for Terumo Aortic.
The Planning Committee has nothing to disclose relevant to this program.
The THI CME Staff has nothing to disclose relevant to this program.
The Program Reviewers has nothing to disclose relevant to this program.
All relevant financial relationships have been mitigated.
Texas Heart Institute Grand Rounds is an esteemed tradition that attracts leading experts from around the world each year. Texas Heart Institute Grand Rounds is hosted in the Denton A. Cooley Auditorium at 6770 Bertner Avenue in Houston, TX.
Series attendees include Cardiology Fellows and Faculty, members of the Departments of Internal Medicine and Cardiovascular Surgery, as well as visitors from other clinical and teaching institutions in the Texas Medical Center. We live broadcast Grand Rounds for online viewing on any desktop computer or mobile device.
Accreditation and Credit Designation
Texas Heart Institute is accredited by the Accreditation Council or Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Questions? Contact CME@texasheart.org
